Evidence map›Paper›PMID 29928692›Full record

ArticleScience advances2018

X chromosome protects against bladder cancer in females via a

Satoshi Kaneko, Xue Li

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. UTX (KDM6A) promotes differentiation noncatalytically in somatic self-renewing epithelia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Review
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Satoshi KanekoDepartment of Urology and Surgery, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.ORCID 0000-0001-8462-3245
Xue LiDepartment of Urology and Surgery, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.ORCID 0000-0002-3072-0573
Boston Children's Hospital · US

Funding

Molecular Basis of Sexually Dimorphic Development of the Genital TubercleR01DK110477 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI LI, XUE SEAN · 2017 to 2021
$1.9M
Gender Difference in Bladder Cancer SusceptibilityR21CA198544 · NCI · BOSTON CHILDREN'S HOSPITAL · PI LI, XUE SEAN · 2015 to 2016
$423k
NCI NIH HHS R21 CA198544NIDDK NIH HHS R01 DK110477
6 · The paper itself

Abstract

Men are much more likely than women to develop bladder cancer (BCa), but the underlying cause of this gender disparity remains poorly defined. Using sex-reversed mice, we show that the sex chromosome complement is an independent cause and, moreover, amplifies the biasing effects of sex hormones. We also show that the X-linked lysine demethylase 6A (

Indexed as

Epigenesis, GeneticGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseX ChromosomeAnimalsCell Transformation, NeoplasticCyclin-Dependent Kinase Inhibitor p21Disease Models, AnimalDisease ProgressionFemaleGenes, X-LinkedGonadal Steroid HormonesHistone DemethylasesMethylationMiceMice, KnockoutCyclin-Dependent Kinase Inhibitor p21Gonadal Steroid HormonesHistone DemethylasesTumor Suppressor Protein p53Tumor Suppressor ProteinsUtx protein, mouse

Identifiers

PMID29928692
PMCPMC6007159
OpenAlexW2807909836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.